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A b s t r a c t  
Dodonaea viscosa (L.) Jaeq (Sapindaceae) is used in traditional medicine for the treatment of 
hemorrhoids, ulcer, and pains of hepatic or stomach origin. The current study was designed to 
investigate the phytochemical constituents of the plant and evaluate its activity against liver fibrosis 
induced by carbon tetrachloride (CCl4) in rats.   The phytochemical analysis has afforded one 
flavanone; 5,7-dihydroxy flavanone (pinocembrin) (1) and eight flavones. The compounds were isolated 
and elucidated as; 5,7-dihydroxy-3,6,4'-trimethoxyflavone (santin) (2), 5,7,4'-trihydroxy-3-methoxy 
flavone (kaempferol 3-O-methyl ether) (3), 3,4',5-trihydroxy-7-methoxy flavone (kaempferol 7-O-methyl 
ether) (4), 3',4',5,7-tetrahydroxy-3-methoxy-flavone (quercetin 3'-O-methyl ether) (5), 3,3',4',5,7-
pentahydroxyflavone (quercetin) (6), 5,7,4'-trihydroxy-3,6-dimethoxy flavone (7), 5,7-dihydroxy 3,6,3',4'-
tetramethoxy flavone (8), and isorhamnetin-3-O-robinobioside (9).. In vitro screening of ethanol extract, 
fractions of toluene and ethyl acetate, the flavanone and major flavone compounds as antioxidants was 
carried out. In addition, D. viscosa ethanol extract and two fractions were examined in vivo against liver 
fibrosis induced by CCl4 in rats. The evaluation was done through measuring hepatic oxidative stress 
markers; malondialdehyde (MDA), glutathione (GSH) and superoxide dismutase (SOD). The work was 
extended to measure serum protein content and liver function enzymes; aspartate and alanine 
aminotransferases (AST and ALT), alkaline phosphatase (ALP) and gamma glutamyl transferase 
(GGT). Liver histopathological analysis was done for results confirmation. In conclusion, among the 
isolated flavones, compounds 3, 4, and 8 were isolated for the first time. The ethanol extract and 
compound of 6, 5 followed by 7 exhibited the strongest antioxidant activities. Treatment with D. viscosa 
extract and its fractions attenuates the increments of MDA, AST, ALT, ALP, GGT, total protein and 
increased GSH and SOD levels. The ethanol extract showed the most potent effect. The data confirmed 
the rationale for the traditional use of D. viscosa extracts to hepatic disorders. Further studies are 
needed in order to evaluate the isolated flavones as protective agents against liver injury and for their 
clinical application.   





The genus Dodonaea (Sapindaceae) is comprised of approximately 
68 species. Previous reports have demonstrated that some 
traditional medicinal plants from the genus Dodonaea are rich in 
flavonoid components [1-4]. Dodonaea viscosa (L.) Jacq. is an 
evergreen shrub widely found in tropical and subtropical regions, 
and it has been used in traditional medicines in various countries [5, 
6]. In various African countries, Surah region of Saudi Arabia and 
other Asian countries, people administered orally the dried leaves 
decoction for treatment of stomach ulcer after grinding and mixing with milk or 
honey, hemorrhoids, and stomachache pains of hepatic or splenic 
origin [3, 4, 6]. Besides the traditional uses, some pharmacological 
studies give an insight of its therapeutic potentials as anti-
inflammatory, antioxidant and hypolipidaemic effect were reported 
[7-9]. 
Liver, an imperative organ, has a crucial role in the metabolic 
pathways that causes liver to succumb to numerous hepatic 
diseases. Carbon tetrachloride (CCl4), as a xenobiotic, caused 
oxidative stress and may injuries hepatic cells [10]. Many studies 
have established the fact that CCl4 is metabolized in the liver into a 
highly reactive substance, trichloromethyl, which initiate free 
radicals that mediate lipid peroxidation process [11].  
Synthetic drugs exploited in the treatment of liver diseases are 
incompetent and may sometimes lead to serious side effects [12]. 
In this regard, herbal therapy has emerged as proficient approach 
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Plants offer a wide range of natural antioxidants due to the 
structural diversities of their secondary metabolites; mainly phenolic 
compounds, with higher potency and lower toxicities than the 
synthetic ones currently available [13, 14]. They may also serve as 
vital source of potentially useful new agents for development of 
effective therapy to combat a variety of liver problems with 
interception of fewer side effects [12, 13, 15].  
Despite the favorable ethnopharmacological properties of D. 
viscosa, its protective effect against liver fibrosis has not previously 
been explored. The aim of the present study was to evaluate the 
ethanolic extract of D. viscosa and the fractions of toluene and ethyl 
acetate against liver fibrosis induced by CCl4 in rats. The evaluation 
was done through measuring certain oxidative stress markers, liver 
function indices and histological analysis of the liver sections. 
  
Materials and methods 
Chemicals 
All chemicals in the present study were high analytical grade 
products from Sigma (USA), Merck (Germany), BDH (England), 
Riedel de Hàen (Germany) and Fluka (Switzerland). 
Plant materials 
The aerial parts of Dodonaea viscosa L. were collected from 
mountains of Al-Aqiq Valley in Al-Baha, Saudi Arabia at altitude of 
800-1200m height in May 2008. They were identified by Dr. Farag 
Abd-Allah Alghamdi, Botany Department, King Abdul-Aziz 
University, Jeddah, Saudi Arabia. Voucher specimens (number: 
N012456) were deposited in King Abdul-Aziz University Herbarium.  
Material for chromatography 
Precoated silica gel 60 F254 plates for thin layer chromatography 
(TLC) and Whatman No. 1 sheets (Whatman Ltd., Maidstone, Kent, 
England) for paper chromatography (PC) were used. Column 
chromatography (CC) was carried out using silica gel (Si) 60 mesh 
of 35-60 and 60-120 (E. Merck, Darmstadt, Germany) or Sephadex 
LH-20 (Pharmacia Fine Chemicals AB, Uppsala, Sweden). 
Apparatus 
Electrothermal digital and Gallenkamp electrothermal melting point 
Apparatus were used. Spectrophotometer model UV – 240 (200-
600 nm). The NMR spectra were recorded at 300 (1H) and 75 (13C) 
MHz on Varian Mercury 300 (Varian, UK) NMR spectrometer; δ 
values are reported as ppm relative to TMS in the convenient 
solvent. EI-MS spectra were recorded on a Finnigan MAT 95 
spectrometer (70 eV) (Finnigan MAT, San Jose, CA). HRESI/MS 
was carried out using Bruker microTOF spectrometer (Bruker-
Daltonics, CA). UV-VIS spectra were recorded on a Perkin-Elmer 
UV/VIS spectrometer (Perkin-Elmer,Norwalk, CT, USA).  
Solvent systems and spray reagent 
S1: Benzene/EtOAc (7:3); S2: Benzene/EtOAc (6:4); S3: 
CHCl3/MeOH (9:1) were used for TLC, while S4: n-
BuOH/HOAc/H2O (4:1:5, top layer); S5: 15 % aqueous HOAc were 
for the PC. All solvents used for extractions and chromatographic 
separations were of analytical grade. AlCl3 spray reagent (1 g 
powder of AlCl3 in 100 mL of ethanol) was used. After spraying, 
heat the dry chromatogram at 105 ºC for 10 min. and visualize 
under UV light. 
Phytochemical study 
Extraction, fractionation and isolation 
The air dried and powdered aerial parts of D. viscosa (2.5 kg) were 
extracted with 80% ethanol at room temperature. The extract was 
concentrated under reduced pressure and temperature not 
exceeding 50 °C to yield 308.9 g (12.36 % dry weight basis). An 
aliquot of the ethanolic extract (150 g) was suspended in water and 
fractionated by extraction with toluene and ethyl acetate till 
exhaustion. The solvent-free extractives (41.28 and 26.48 g, 
respectively) were saved for isolation of the major constituents. The 
fractions were screened by TLC and/or PC using S1–S5 as solvent 
systems. The chromatograms were examined under UV light before 
and after exposure to ammonia vapor, as well as, after spraying 
with the reagent. Part of toluene fraction (30 g) was fractionated on 
a Si CC. Elution was carried out using petroleum ether, petroleum 
ether-toluene mixtures with increasing polarity till toluene, then ethyl 
acetate. Fractions, 100 mL each, were collected and monitored by 
TLC, using S1 – S3 as solvent systems and AlCl3 spray reagent. 
Fractions of similar chromatographic profile were pooled to yield 
four main fractions. These fractions were chromatographed on 
different columns viz., silica gel column chromatography (eluted 
successively with a step gradient of toluene/EtOAc (100:0 - 0:100 
v/v) then gradual increase polarity with methanol) and Sephadex 
LH-20 using methanol as eluent. Compounds 1 – 6 were isolated, 
their purity being checked by comparative TLC using solvent 
systems S1 – S3. The ethyl acetate fraction was subjected to Si CC; 
being eluted with n-hexane-ethyl acetate to give three fractions. The 
fractions were monitored by TLC and/or PC, using S3 – S5 for the 
isolated compounds (7 – 9). 
Identification of compounds 
The structures of isolated compounds were elucidated by 
spectroscopic methods including UV, NMR, EI-MS, and HR-EMS as 
well as comparison with published data [16 - 19]. 
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5,7-dihydroxy flavanone (pinocembrin) (1) R1 R2 R3 R4 R5 
5,7-Dihydroxy-3,6,4'-trimethoxyflavone (Santin) (2) H OCH3 OCH3 CH3 H 
5,7,4'-Trihydroxy-3-methoxy flavone (Kaempferol 3-O-methyl ether) (3) H H OCH3 H H 
3,5,4'-Trihydroxy-7-methoxy flavone (Kaempferol 7-O-methyl ether) (4) CH3 H OH H H 
3,5,7,4'-Tetrahydroxy-3'-methoxy flavone (Quercetin 3'-O-methyl ether) (5) H H OH H OCH3 
3,5,7,3',4'-Pentahydroxyflavone (Quercetin) (6) H H OH H OH 
5,7,4'-Trihydroxy-3,6-dimethoxy flavone (7) H OCH3 OCH3 H H 
5,7-Dihydroxy-3,6,3',4'-tetramethoxy flavones (8) H OCH3 OCH3 CH3 OCH3 
Isorhamnetin-3-O-robinobioside (9) H H Gal-Rha H OCH3 
 
Fig. 1: Chemical structures of Dodonaea viscosa isolated compounds. 
 
Bioactivity assays 
In vitro antioxidant effect 
In vitro antioxidants screening of D. viscosa ethanol extract, its 
toluene and ethyl acetate fraction as well as the flavanone (1) and 
major flavones (2, 5-9) was carried out by the method of Chen et 
al. (2007) [20]. Serial concentrations (10:100µg) for each tested 
sample were estimated, where 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) free radicals react with plant antioxidants and the 
decrease in absorbance (A) of DPPH was calculated in relation to 
absorbance of control as follows: 
 % IP  =   (A control - A sample) /A control x 100  
In vivo study 
Animals                                
Male Wistar albino rats (100: 120 g) were selected for this study. 
They were obtained from the Animal House, National Research 
Center, Egypt. All animals were kept in controlled environment of 
air and temperature with access of water and diet. Anesthetic 
procedures and handling with animals complied with the ethical 
guidelines of Medical Ethical Committee of National Research 
Centre in Egypt.  
 
Doses and root of administration 
Administration regimen was twice a week for six consecutive 
weeks. CCl4 (0.5 mL/kg) was suspended in olive oil (1:9 v/v) and 
injected intraperitoneally [21]. Ethanolic extract and the fractions of 
toluene and ethyl acetate of Dodonaea viscosa were, separately, 
administrated orally at a dose of 200 mg/kg [8]. Silymarin; a 
reference herbal drug was orally administered at a dose of 100 
mg/kg [22].  
 
Experimental groups 
48 Male Wistar strain albino rats were used in this study. Animals 
were divided into 6 groups (8 rats each). Group 1 served as 
normal healthy control rats. Group 2 injected with CCl4. Groups 3 - 
5 forced at the same time with CCl4 and D. viscosa extracts 
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Biological sample preparations   
Liver tissue was homogenized in normal physiological saline 
solution (0.9% NaCl) (1:10 w/v). The homogenate was centrifuged 
at 3000 xg for 5 minutes (4 ºC) and the supernatant was used for 
estimation of hepatic oxidative stress markers. 
Serum sample: Blood collected from each animal by puncture the 
sublingual vein in clean and dry test tube, left 10 min to clot and 
centrifuged at 3000 xg (4ºC) for serum separation. The separated 
serum was stored at -80 ºC for further determinations of liver 
function enzymes and serum protein. 
Biochemical assays 
Oxidative stress markers 
Malondialdehyde; a marker of lipid peroxidatition process was 
estimated by method of Buege and Aust (1978) at 535 nm [23]. 
Glutathione was assayed by Moron et al. (1979) using dithiobis-2-
nitrobenzoic acid (DTNB) in PBS at 412 nm [24]. Superoxide 
dismutase was estimated by method of Nishikimi et al. (1972) [25], 
where the increase in absorbance of reduced nicotinamide 
adenine dinucleotide (NADH) was measured at 560 nm using its 
molar extinction coefficient 6.22 x 103 M-1 cm-1. 
 
Serum biomarkers for liver function tests 
Aspartate and alanine aminotransferases were measured by the 
method of Gella et al. (1985) [26], where the transfer of amino 
group from aspartate or alanine formed oxalacetate or pyruvate, 
respectively and the developed colour was measured at 520 nm. 
Alkaline phosphatase catalyzed in alkaline medium the transfer of 
phosphate group from 4-nitrophosphatase to 2-amino-2-methyl-1-
propanol (AMP) and librated 4-nitrophenol. The developed colour 
was measured at 510 nm [27].  GGT was estimated by the method 
of Szasz (1969) [28], where GGT enzyme reacted with L-γ-
glutamyl-3-carboxy-p-nitroanilide and glycyl-glycine to give L-γ–
glutamyl-glycyl-glycine and 5-amino-2-nitrobenzoate. The 
decrease in absorbance was read at lmax of 450 nm at 1 min 
intervals for 3 min.  
Total protein level 
Total protein was assayed by the method of Bradford (1976) [29], 
where Coomassie Brilliant Blue dye reacted with Bradford reagent 
and gave a blue complex at lmax 595 nm. 
Histopathological analysis 
Liver slices were fixed in 10% paraformaldehyde and embedded in 
paraffin wax blocks. Sections of 5μm thick were stained with 
hematoxylin & eosin (H&E) and Masson’s trichrome, then 
examined under light microscope for determination of pathological 
changes [30].  
Statistical analysis 
All data were expressed as mean ± S.D. of eight rats in each 
group. Statistical analysis was carried out by one-way analysis of 




Phytochemical investigation of the plant aerial parts resulted in the 
isolation of one flavanone and eight flavones. Their spectral data 
were illustrated as the following: 
 
Compound (1): C15H12O4; 24 mg; Rf:  0.83 (S1), 0.73 (S2); white 
needles; 197-198°C; UV spectral data: lmax, nm (MeOH): 232 sh, 
290, 338 sh; (+NaOMe): 247, 328; (+AlCl3): 312, 377; 
(+AlCl3/HCl): 310, 377; (+NaOAc): 232, 332; (+NaOAc/H3BO3): 
236, 293, 336 sh; MS: m/z (%): 256 (M+, 41.8), 257 [(M+H)+, 7.8], 
255 [(M-H)+, 44.3], 238 [(M-H2O)+, 6.5], 179 [(M-C6H5)+, 55.7], 153 
[A1++H, 15.6], 152 [A1+, 53.9], 124 [A1+- CO, 58.2], 104 [B1+, 34.8], 
77 [C6H5+, 81.6], 51 [C6H5+- C2H2, 100]; 1H NMR (DMSO-d6, 300 
MHz): d ppm 12.12 (s, OH-5), 7.38-7.50 (5H, m, H-2'/3'/ 4'/5'/6'), 
5.92 (1H, d, J~2 Hz, H-8), 5.90 (1H, d, J~2 Hz, H-6), 5.57  (d, 
J=12.6 Hz, H-2), 3.24 (1H, dd, J=12.6, 16.8 Hz, H-3α), 2.78 (1H, d, 
J=17.1 Hz, H-3β); 13C NMR (DMSO-d6, 75 MHz): d ppm 195.8 (C-
4), 166.7 (C-7), 163.4 (C-5), 162.6 (C-9), 138.6 (C-1'), 128.5 (C-
3'/4'/5'), 126.5 (C-2'/6'), 101.7 (C-10), 95.9 (C-6), 95.0 (C-8), 78.3 
(C-2), 42.1 (C-3) (Fig.1). 
 
Compound (2): C18H16O7; 32 mg; Rf:  0.72 (S1), 0.76 (S2); yellow 
ppt, 161-162ºC; UV spectral data: lmax, nm (MeOH): 273, 343; 
(+NaOMe): 278, 297, 371; (+AlCl3): 281, 305 sh, 360, 409; 
(+AlCl3/HCl): 283, 305 sh, 354, 409 sh; (+NaOAc): 273, 299 sh, 
367; (+NaOAc/H3BO3): 273, 343; MS m/z (%): 344 [M+, 100], 345 
[(M+H)+, 35.6], 330 [M+- CH3/+H, 19.4],    329 [M+ - CH3, 58.3], 
301 [M+ - CO/CH3, 48.2], 283 [301- H2O, 25.0], 258 [301 -
CO/CH3, 11.0], 135 [B2+, 18.5], 132 [B1+, 6.4]; 1H NMR (DMSO-d6, 
300 MHz): d ppm 12.70 (1H, s, OH-5), 7.93 (2H, d, J=8.7 Hz, H-
2'/6'), 7.03 (2H, d, J=8.7 Hz, H-3'/5'), 6.49 (1H, s, H-8), 3.81 (3H, 
s, OCH3-6), 3.76 (3H, s, OCH3-3), 3.72 (3H, s, OCH3-4'); 13C NMR 
(DMSO-d6, 75 MHz): d ppm 178.1 (C-4), 161.2 (C-4'), 157.2 (C-7), 
155.0 (C-2), 152.3 (C-5), 151.5 (C-9), 137.5 (C-3), 131.1 (C-6), 
129.7 (C-2'/6), 122.2 (C-1'), 114.0 (C-3'/5'), 104.6 (C-10), 93.9 (C-
8), 59.8 (OCH3-6), 59.6 (OCH3-3), 55.3 (OCH3-4') (Fig.1). 
 
Compound (3): C16H11O6; 13 mg; Rf: 0.60 (S4), 0.16 (S5); m.p. 
237-242ºC; yellow needle crystals; UV spectral data: lmax, nm 
(MeOH): 266, 297 sh, 348; (+NaOMe): 274, 324 sh, 398; (+AlCl3): 
274, 305 sh, 350 sh, 399; (+AlCl3/HCl): 274, 305sh, 347 sh, 399. 
(+ NaOAc): 274, 309 sh, 386; (+ NaOAc/H3BO3): 266, 303sh, 350; 
MS: m/z (%): 300 ((M+, 100), 299 (M+-H, 89), 282 (M+-H2O, 37), 
257 (M+-CH3CO, 73); 1H NMR (DMSO-d6, 300 MHz): d ppm 7.92 
(2H, d, J=9 Hz, H-2'/6'), 6.93 (2H, d, J=9 Hz, H-3'/5'), 6.37 (1H, d, 
J=2.1 Hz, H-8), 6.14 (1H, d, J=2.1 Hz, H-6), 3.77 (3H, s, OCH3-3). 
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13C NMR (DMSO-d6, 75 MHz): d ppm 177.8 (C-4), 164.0 (C-7), 
161.1 (C-9), 160.0 (C-4'), 156.3 (C-5), 155.5 (C-2), 137.5 (C-3), 
129.9 (C-2'/6'), 120.5 (C-1'), 115.5 (C-3'/5'), 104.1 (C-10), 98.5 (C-
6), 93.6 (C-8), 59.6 (OCH3-3) (Fig.1). 
 
Compound (4): C16H11O6;  12 mg;  Rf:  0.68 (S1), 0.51(S2); yellow 
powder, 224-225°C; UV spectral data: lmax, nm (MeOH): 270, 
363; (+NaOMe): 278, 399; (+AlCl3): 274, 305 sh, 348, 424; 
(+AlCl3/HCl): 274, 305 sh, 348, 424; (+NaOAc): 276, 364; 
(+NaOAc/H3BO3): 276, 364; 1H NMR (DMSO-d6, 300 MHz): d 
ppm 12.45 (1H, s, OH-5), 8.03 (2H, d, J=8.7 Hz, H-2'/6'), 6.92 (2H, 
d, J=8.7 Hz, H-3'/5'), 6.44 (1H, d, J=2.4 Hz, H-8), 6.19 (1H, d, 
J=2.1 Hz, H-6), 3.46 (3H, s, OCH3-7). 13C NMR (DMSO-d6, 75 
MHz): d ppm 176.0 (C-4), 164.0 (C-7), 160.8 (C-5), 159.3 (C-4'), 
156.4 (C-9), 147.2 (C-2), 135.8 (C-3), 129.7 (C-2'/6'), 121.8 (C-1'), 
115.6 (C-3'/5'), 106.0 (C-10), 98.4 (C-6), 93.7 (C-8), 57.0 (OCH3-
7) (Fig.1). 
 
Compound (5): C16H12O7; 19 mg, Rf: 0.52 (S1), 0.36 (S2); yellow 
powder, 314-415°C; UV spectral data: lmax, nm (MeOH): 254, 300 
sh, 374; (+NaOMe): 274, 321, 412; (+AlCl3): 265, 305 sh, 353, 
428; (+AlCl3/HCl): 265, 305 sh, 353, 428; (+NaOAc): 257 sh, 274, 
331, 388; (+ NaOAc/H3BO3): 254, 274 sh, 374; MS: m/z (%): 316 
(M+, 100), 301 (M+- CH3, 9.9), 288 (M+-CO, 4.9), 287 (M+-CHO, 
10.2), 273 (C14H9O6+, 7.2), 245 (C13H9O5+, 10.1), 153 [(A1+H) +, 
6.2], 151 (B2+, 5.9); 1H NMR (DMSO-d6, 300 MHz): d ppm 12.44 
(1H, s, OH-5), 7.77 (1H, dd, J=1.2, 8.7 Hz, H-6'), 7.69 (1H, d, 
J=1.2 Hz, H-2'), 6.93 (1H, d, J=8.7 Hz, H-5'), 6.46 (1H, s, H-8), 
6.18 (1H, s, H-6), 3.92 (3H, s, OCH3-3'); 13C NMR (DMSO-d6, 75 
MHz): d ppm 176.3 (C-4), 164.4 (C-7), 161.2 (C-5), 156.8 (C-9), 
149.4 (C-3'), 147.1 (C-4'), 147.1 (C-2), 136.1 (C-3), 122.6 (C-1'), 
122.2 (C-6'), 116.0 (C-5'), 112.6 (C-2'), 103.5 (C-10),  98.6 (C-6), 
93.4 (C-8), 55.7 (OCH3-3') (Fig.1). 
 
Compound (6): C15H10O7; 24 mg, Rf: 0.61 (S4), 0.25 (S5); yellow 
powder; m.p.: 316-318°C; UV spectral data: lmax, nm (MeOH): 
258, 300 sh, 372; (+NaOMe): 274, 325, 410; (+AlCl3): 272, 330 sh, 
449; (+AlCl3/HCl): 265, 305 sh, 357, 430; (+NaOAc): 257, 378; (+ 
NaOAc/H3BO3): 363, 388; MS: m/z (%): 302 [M+, 100], 301 [(M-
H)+, 24.0], 273 [M+-CHO, 4.0], 245 [M+-CHO/CO, 8.0], 153 
[(A1+H)+, 4.0], 137 [B+2, 9.4]; 1H NMR (DMSO-d6, 300 MHz): d 
ppm 12.47 (1H, s, OH-5), 7.67 (1H, d, J=2.1 Hz, H-2'), 7.53 (1H, 
dd, J=2.1, 8.7 Hz, H-6'), 6.88 (1H, d, J=8.7 Hz, H-5'), 6.41 (1H, d, 
J=1.5 Hz, H-8), 6.18 (1H, d, J=1.5 Hz, H-6); 13C NMR (DMSO-d6, 
75 MHz): d ppm 176.3 (C-4), 164.3 (C-7), 161.1 (C-5), 156.7 (C-
9), 148.1 (C-2), 147.4 (C-4'), 145.5 (C-3'), 136.1 (C-3), 122.5 (C-
1'), 120.7 (C-6'), 116.1 (C-5'), 115.5 (C-2'), 103.5 (C-10), 98.8 (C-
6), 94.0 (C-8) (Fig.1). 
 
Compound (7): C17H14O7; 34 mg, Rf : 0.47 (S1), 0.55 (S2); yellow 
crystals; m.p. 210-212°C; UV spectral data: lmax, nm (MeOH): 
272, 342; (+NaOMe): 277, 329, 400; (+AlCl3): 278, 307 sh, 360, 
406 sh; (+AlCl3/HCl): 283, 307 sh, 360, 406 sh; (+NaOAc): 273, 
369; (+NaOAc/H3BO3): 273, 301 sh, 342; MS: m/z (%): 330 [M+, 
100], 329 [(M-H)+, 42.7], 316 [M+-CH3/+H, 12.2], 315 [M+-CH3, 
47.9], 312 [(M-H2O)+, 42.0], 287 [M+-CH3/CO, 47.3], 269 [287-
H2O, 32.9], 167 [A1+, 8], 121 [B2+, 36.2]; 1H NMR (DMSO-d6, 300 
MHz): d ppm 12.75 (1H, s, OH-5), 7.92 (2H, d, J=8.7 Hz, H-2'/6'), 
6.93 (2H, d, J=8.7 Hz, H-3'/5'), 6.53 (1H, s, H-8), 3.77 (s, 3H, 
OCH3-6), 3.75 (3H, s, OCH3-3); 13C NMR (DMSO-d6, 75 MHz): d 
ppm 178.1 (C-4), 160.1 (C-4'), 157.2 (C-7), 155.6 (C-2), 152.3 (C-
5), 151.5 (C-9), 137.2 (C-3), 131.2 (C-6), 130.0 (C-2'/6'), 120.6 (C-
1'), 115.6 (C-3'/5'), 104.5 (C-10),  93.9 (C-8), 59.9 (OCH3-6), 59.6 
(OCH3-3) (Fig.1). 
 
Compound (8): C17H14O7; 19 mg; Rf: 0.92 (S4), 0.13 (S5); 
yellowish white amorphous; UV spectral data: lmax, nm (MeOH): 
257, 270 sh, 346; (+NaOMe): 269, 300 sh, 408; (+AlCl3): 270, 280 
sh, 300 sh, 352, 400 sh; (+AlCl3/HCl): 263, 270 sh, 356, 390 sh; 
1H NMR (CDCl3, 300 MHz): d ppm 7.64 (1H, d, J=1.9 Hz, H-2'), 
7.60 (1H, dd, J=8.7, 1.9 Hz, H-6'), 6.99 (1H, d, J=8.7 Hz, H-5'), 
6.44 (1H, s, H-8), 3.92, 3.89, 3.85, 3.79 (3H, s each, 4x OCH3); 
13C NMR (CDCl3, 75 MHz): d ppm 178.7 (C-4), 158.6 (C-7), 155.8 
(C-2), 152.6 (C-9), 152.1 (C-5), 148.2 (C-4'), 146.2 (C-3'), 138.5 
(C-6), 132.1 (C-3), 122.5 (C-6'), 122.3 (C-1'), 114.5 (C-5'), 110. 8 
(C-2'), 106.5 (C-10), 90.3 (C-8), 60.9 (OCH3-6), 60.2 (OCH3-3), 
56.3 (OCH3-3'), 56.1 (OCH3-4') (Fig.1). 
 
Compound (9): C22H32O16; Rf:  0.12 (S1), 0.15 (S2); 20 mg, yellow 
granules, m.p. 190-191°C; HRMSI MS m/z: 625 [M+H]+, 479 [M+-
Rha], 317 [aglycone+H]+, -ve MS: 623 [M-H]+; 1H NMR (DMSO-d6, 
300 MHz): d ppm 8.01 (1H, d, J=2.1 Hz, H-2'), 7.59 (1H, dd, J=2, 
8.7 Hz, H-6'), 6.90 (1H, d, J=8.4 Hz, H-5'), 6.37 (1H, d, J=2.1 Hz, 
H-8), 6.18 (1H, d, J=2.1 Hz, H-6), 5.19 (1H, d, J=7.8 Hz, H-1''), 
4.95 (1H, br s, H-1'''), 3.96 (3H, s, OCH3-3'), 3.8-3.3 (m, remaining 
sugar moiety), 1.17 (3H, d, J=6.3 Hz, CH3); 13C NMR (DMSO-d6, 
75 MHz): d ppm 177.4 (C-4), 164.5 (C-7), 161.2 (C-5), 156.5 (C-
9), 156.4 (C-2), 147.0 (C-4'), 149.5 (C-3'), 132.9 (C-3), 122.0 (C-
6'), 121.2 (C-1'), 115.2 (C-5'), 113.6 (C-2'), 104.1 (C-10), 101.8 (C-
1''), 100.1 (C-1'''), 98.8 (C-6), 93.8 (C-8), 73.6 (C-5''), 73.0 (C-3''), 
71.9 (C-4'''), 71.1 (C-2''), 70.6 (C-3'''), 70.4 (C-2'''),  68.3 (C-5'''), 
68.0 (C-4''), 65.2 (C-6''), 55.9 (OCH3-3'), 18.0 (C-6''') (Fig.1). 
Bioactivity study 
In vitro antioxidant activity 
In vitro antioxidants screening of D. viscosa ethanol extract, its 
toluene and ethyl acetate fractions as well as the flavanone (1) 
and major flavones (2, 5, and 7-9) was carried out. All tested 
samples scavenge DPPH free radicals by variable degrees 
ranging from 12.50% to 80.00% (Table 1). The ethanol extract 
recorded the highest inhibition level of DPPH free radicals 
(80.00%) than the fractions of toluene (68.75%) and ethyl acetate 
(46.00%) (Table 1). Compound 5 showed remarkable antioxidant 
activity compared to the other tested flavones. 
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Table 1 Inhibition percentage of DPPH radicals after treatment 
with D. viscosa samples. 
Sample DPPH- inhibition(%) 
Ethanol extract 80.00 
Toluene extract 68.75 
Ethyl acetate  
extract 79.00 
Compound (1) 75.00 
Compound (2) 46.00 
Compound (5) 80.00 
Compound (6) 96.40 
Compound (7) 61.14 
Compound (8) 48.07 
Compound (9) 12.50 




Oxidative stress markers 
Malondialdehyde (MDA) showed significant increase in CCl4 group 
by 40% (Table 2). Treated group with ethyl acetate extract still 
recorded significant increase (22.66%) as compared with normal 
control group, while treatment with ethanol, toluene and silymarin 
showed insignificant changes. Treatment with ethanol extract 
showed the most improvement in MDA level (36.00%) comparing 
with the reference drug silymarin (38.67%) (Table 2). CCl4 group 
showed significant decrease in glutathione (62.94%) and 
superoxide dismutase (49.33%). Treatment with different extracts 
and silymarin recorded significant decrease in GSH and SOD. 
Glutathione showed significant decrease by 16.85, 27.21, 39.33 
and 21.89% after treatment with ethanol, toluene, ethyl acetate 
and silymarin, respectively, while SOD decreased by 28.00, 38.66, 
40.80 and 28.00%, respectively (Table 2). Treatment with ethanol 
extract showed the most potent improvement in GSH (46.09%) 
and SOD (21.33%) levels (Table 3). 
Table. 2 Effect of different extracts on hepatic oxidative stress markers in CCl4 treated rats. 
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Data are means ± SD of eight rats in each group. 
 Data are expressed as µg/mg protein for GSH and µmol/mg protein for MDA and SOD. 
Superscript unshared letters between groups are the significance values at p< 0.0001. 
Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program. 
Values between brackets are improvement percentage (%) =     Mean of treated group - Mean of  CCl4 group  x 100           
                                                                                                        Mean of control group 
Table 3 Effect of different extracts on liver function enzymes and serum protein level in CCl4 treated rats. 
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· Data are means ± SD of eight rats in each group. 
· Liver functions are expressed as Unit/L.  Total protein is expressed as mg P/ ml. 
· Superscript uUnshared letters between groups are the significance values at p< 0.0001. 
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· Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program. 
· Values between brackets are improvement percentages (%) = Mean of treated group - Mean of CCl4 group x100           
Mean of control group 
 
 
Fig.2: Photomicrograph of hematoxylin and eosin (H & E) and Masson’s trichrome stained liver section (100x) of 
control (a,b), CCl4 (c,d) and silymarin (e,f) treated groups. Arrows indicate well arranged hepatocytes. Small arrows 
indicate collagen deposition and swollen hepatocytes. 
 
Liver function enzymes 
In case of liver function enzymes, CCl4 group recorded significant 
increase in AST, ALT, ALP and GGT by 52.11, 48.20, 87.75 and 
65.07%, respectively. Treatment with ethanol and toluene extracts 
showed insignificant increase in liver function enzymes as 
compared with the normal control group. Treatment with ethyl 
acetate extract still recorded significant increase in AST, ALT and 
ALP by 43.66, 25.07 and 40.81%, respectively. Treatment with 
silymarin showed insignificant increase in liver function parameters 
(Table 3). Highly improvement levels in liver functions were 
recorded after treatment with ethanol extract. It reached to 40.84, 
45.54, 67.35 and 47.61% for AST, ALT, ALP and GGT, respectively 
(Table 3). 
 
Serum total protein level 
CCl4 group recorded significant increase by 51.78%. Insignificant 
changes were observed after treatment with plant extracts and 
silymarin as compared to normal control group (Table 3). Ethanol 
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extract showed the highest amelioration in protein level (39.28%) 
than the other extracts, while silymarin treatment recorded 
improvement by 46.43% (Table 3). 
Liver histopathological analysis 
Liver section of control healthy rats showed normal hepatic lobular 
architecture (Figure 2 a,b). The hepatocytes were within normal 
limits and arranged in thin plates. No fibrous tissue or lymphocytes 
deposition were observed. Liver injured with CCl4 revealed portal 
loss of hepatic lobular architecture. Ballooning of hepatocytes, 
deformed cord arrangement and disturbed sinusoids were seen. 
Portal tracts were extended with marked number of chronic 
inflammatory cells and fibrous tissue (Fig. 2 b,c). CCl4 group treated 
with silymarin showed swelling and foamy appearance of 
hepatocytes. Hydropic changes were also seen. Mild fibrotic tissue 
was still present (Figure 2e,f). 
 
 
Fig.3: Photomicrograph of hematoxylin and eosin (H & E) and Masson’s trichrome stained liver section (100x) of CCl4 
group treated with ethanol (a,b), toluene (c,d) and ethyl acetate (e,f) extracts. Arrows indicate collagen deposition. 
Small arrows indicate swollen hepatocytes. 
 
Treatments of injured liver with the ethanol extract showed well 
formed nucleated hepatocytes. Mild inflammatory lymphocyte 
infiltration and mild fibrosis were seen (Figure 3 a,b). Toluene 
extract partly preserved the hepatic architecture with mild degree 
of hydropic changes. The hepatocytes were still swollen with 
narrow sinusoids. Portal tracts were extended with mild fibrous 
tissue (Figue 3 c,d). Ethyl acetate extract showed ballooning of 
hepatocytes that lost its arrangement with narrow sinusoides due 
to hepatocytes enlargement (Figure 3 e). Moderate fibrous tissue 
war recorded (Figure 3 f). 
 
Discussion 
In the present study, the known flavones 2-9 as well as flavanone 
1 were isolated. The identification of the isolated flavones was 
confirmed by MS, UV and NMR spectra as well as co-
chromatography with available authentic samples. 
 
Compound 1 showed lmax 232, 290, and 328 nm in methanol 
characteristic for flavanone structure. The 1H-NMR spectrum 
showed a two proton aromatic signals doublets at d 5.92 and 
5.90 ppm (J~ 2 Hz) for H-8 and H-6, respectively. A 
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monosubstituted aromatic ring and a CH-CH2- system [5.57 ppm 
(d, J=12.6 Hz, H-2), 3.24 ppm (dd, J=12.6, 16.8 Hz, H-3α) and 
2.78 ppm (d, J=17.1 Hz, H-3β)], thus suggesting a flavavnone 
skeleton. 13C NMR showed resonance of 15 carbons in which C-
3 appeared at d 42.1 ppm and C-2 at d 78.3 ppm. C-7 and C-5 
appeared at downfield of d 166.7 and 163.4 ppm, respectively so 
they occupied by free OH. The spectral data of 1H-1H COSY, 
HMQC and HMBC supported the structure of 1 as 5,7-dihydroxy 
flavanone (pinocembrin) [16, 31]. 
UV spectral data of compounds 2 - 9 showed two absorptions at 
lmax the range of 250-270 nm  of band II and anther at the range 
of 330-350 nm of band I indicated that they may be 3-substituted 
flavonol or flavone [18]. 
 
The UV data were in agreement with the presence of a free 4'-
hydroxyl group in compounds 3-7 and 9 as shown by the strong 
increase in band I with NaOMe, while 2 and 8 showed a 
diminished peak confirming a substituted 4'-OH. 
Absence of bathochromic shift in band II after addition NaOAc 
reagent indicated a substituted 7-OH group in the structures of all 
compounds, except compound 7. 
The lack of bathochromic shift in NaOAc/H3BO3 spectrum 
indicates the absence of orthodihydroxy group in ring B in all 
compounds, except compound 6. The presence of 
orthodihydroxy group in compound 6 was proved also by the 
observed hypsochromic shift in band I with AlCl3/HCl as a shift 
reagent. 
The AlCl3 spectrum showed a relatively large bathochromic shift 
in all compounds indicating the existence of OH-5 and/or OH-3. 
1H NMR spectra of compounds 2-9 showed correlation to each 
other of flavones structure. The most downfield shifted peak was 
at d 175.8-179.3 ppm, which was assigned to ketone group C-4. 
Two 13C NMR at  d 129.7-130.0 ppm and  d 114.0-115.6 ppm, 
which were attached directly to the 1H peaks at  d 7.92-8.03 ppm 
and  d 6.92-7.03 ppm, respectively, corresponding to C-2'/6' and 
C-3'/5' for compounds 2-4 and 7 [1, 19, 32, 33]. 
The single proton singlet at  d 6.37-6.53 ppm was assigned to H-
8 in all the isolated compounds. 
The presence of a methoxyl group at C-6 could be deduced from 
the corresponding signals at  d 131.1, 132.1 and 132.1 ppm of 
compounds 2, 7 and 8 respectively. 
A low field of C-5 and C-7 at d 152.1 -152.3 ppm and  d 157.2-
158.7 ppm in the spectrum of compounds 2, 7 and 8, 
respectively, again indicated the presence of a methoxyl group. 
Furthermore, the downfield shifts of C-3 in compounds 2, 3, 7 
and 8 at  d 137.5, 137.5, 137.2 and 138.5ppm, respectively. 
Galactose and rhamnose signals were observed in the 13 C NMR 
spectrum of 9. Two anomeric proton signals at δ 5.19 (d, J = 7.8 
Hz, H-1'') and δ 4.95 (brs, H-1'') observed in the 1H NMR 
spectrum. 
The glycosylation site at C-3 hydroxyl of compound 9 was 
confirmed through the downfield resonance of C-2 at d 156.4 
ppm and the upfield signal of C-3 at d 132.9 ppm. 
The downfield shift of about 4.9 ppm for C-6'' and an upfield shift 
of about 2.0 ppm for C-5'' of galactose further was indicated the 
interglycosidic linkage at C-6'' of galactose. These results 
revealed the internal sugar was galactose and external sugar 
was rhamnose. On the basis of these data and comparison with 
the reported NMR data [34, 35] the structure of the compound 9 
was identified as isorhamnetin 3-O-β-D-(6-O-α-L-rhamnosyl) 
galactoside (isorhamnetin 3-robinobioside). 
The known compounds were to be 5,7-dihydroxy flavanone 
(pinocembrin) (1)[1, 31, 36] and eight flavones were isolated and 
elucidated as following; 5,7-dihydroxy-3,6,4'-trimethoxyflavone 
(santin) (2) [19, 32], 5,7,4'-trihydroxy-3-methoxy flavone 
(kaempferol 3-O-methyl ether) (3), 3,4',5-trihydroxy-7-methoxy 
flavone (kaempferol 7-O-methyl ether) (4), 3',4',5,7-tetrahydroxy-
3-methoxy-flavone (quercetin 3'-O-methyl ether) (5) [16], 
3,3',4',5,7-pentahydroxyflavone (quercetin) (6) [16], 5,7,4'-
trihydroxy-3,6-dimethoxy flavone (7) [1, 32, 33], 5,7-dihydroxy 
3,6,3',4'-tetramethoxy flavone (8) and isorhamnetin-3-O-
robinobioside (9) [34, 35]. 
The previously isolated compounds from D. viscosa were; 
compound of 1 and 9 [36], 2 [33], 5 and 6 [37], and 7 [33, 38]. 
While in the present study; compound of 3, 4, and 8 were 
isolated for the first time from Dodonaea species. Compounds 3 - 
5 are methyl ethers known as a group of rare naturally occurring 
compounds. 
The position of hydroxyl groups and other features in the 
chemical structure of flavonoids are important for their antioxidant 
and free radical scavenging activities. Compound 6 (3,5,7,3',4'-
pentahydroxyflavone) showed the highest antioxidant activity. 
Antioxidant activity usually increased with an increase in the 
number of hydroxyl groups as previously reported [39]. Also, 
compound 5 (3'-methoxy-3',4',5,7-tetrahydroxyflavone) showed 
higher antioxidant activity than compound 7 (5,7,4'-trihydroxy-
3,6-dimethoxy flavone). The last compound showed higher 
antioxidant activity compared with compound 8 (5,7-dihydroxy 
3,6,3',4'-tetramethoxy flavone). The results are in agreement with 
the study of Fukumoto and Mazz (2000) [39].  They reported that 
compounds with three hydroxyl groups on the B ring of flavonoids 
had high antioxidant activity. The loss of one hydroxyl group 
decreased activity slightly, whereas the loss of two hydroxyl 
groups significantly decreased activity [39]. Antioxidant activity 
usually increased with a decrease in glycosylation. The current 
study showed higher activity of compound 5 compared to its 
glycoside derivative of compound 9. The hydroxyl group is 
present in compound 5 while it was substituted in compounds of 
7-9. Flavonoids with 3-OH group play a positive role in 
antioxidant activities [40].  It is believed that these structure 
activity relationship results can be taken into account for the 
development of flavonoids with high therapeutic index. It appears 
that methylation of 3-OH in compound 5 reduced activity when 
compared with compound 2 with free 3-OH. This observation is in 
agreement with the earlier structural activity study [41, 42]. 
Due to extensive methoxylation (3-OMe, 4'-OMe and 6-OMe) of 
compound 2 and 8, they may demonstrate less activity than the 
Hamed et al. International Journal of Phytomedicine 4 (1) 27-39 [2012] 
 




other compounds. This observation suggests that 5-OH does not 
play a strong role in antioxidant activity of the investigated 
compounds. This is also in line with the earlier report on 
flavonoids [43]. It was also observed the slight higher activity of 
compound 2 than 8 may related to the excess 3'-OMe of the last 
compound. 
Carbon tetrachloride is a toxic compound used extensively for 
enhancement of oxidative stress [10]. Many studies have 
established the fact that CCl4 is metabolized in the liver into a 
highly reactive trichloromethyl, which initiate free radicals that 
mediate lipid peroxidation [11] and generate ROSs [12]. However, 
when a condition of oxidative stress establishes, the defense 
capacities against ROS becomes insufficient. Therefore, ROS 
affects the antioxidant defense mechanisms, reduces the 
intracellular concentration of glutathione (GSH), decreases the 
activity of superoxide dismutase (SOD) and enhances lipid 
peroxidation (LPO) [44]. This was confirmed by the observed 
reduction in GSH and the increase in malondialdehyde after CCl4 
intoxication. The decline in the activity of free radical scavenging 
enzyme SOD may be due to its inactivation caused by excess 
reactive oxygen species production. SOD neutralizes superoxide; 
that cannot cross lipid membrane, then produce hydrogen 
peroxide and cross biological membranes. So, reduction in SOD 
may damage the first line of enzymatic defense against 
superoxide anion and hydrogen peroxide [45]. The significant 
depletion of GSH indicates damage to the second line of 
antioxidant defense. Gharib et al. (1999) [46] attributed the 
decrease in glutathione level to increased cytoxicity by H2O2 
which is produced as a result of inhibition of glutathione 
reductase that keep glutathione in its reduced form.  
Treatment with D. viscosa extracts normalized the antioxidant 
levels through their rich of compounds of kaempferol and its 
methyl ether derivatives using DPPH free radicals technique [43]. 
Silymarin as an antioxidant flavonoid complex was reported to 
have the ability to attenuate free radicals elevation, chelates 
metal ions, inhibits lipid peroxidation and prevents liver 
glutathione depletion [47]. 
ALT and AST had been reported to be sensitive indicators of liver 
injury [48]. Significant elevation of ALT and AST after CCl4 
intoxication was in agreement with the reported studies [12, 49]. 
In addition, Romero et al. (1998) [50] showed that CCl4 
intoxication induced changes in the process of protein synthesis. 
Hence, increase in total protein content can be deemed as a 
useful index of the severity of cellular dysfunction in liver 
diseases as clearly shown in our studies. Stimulation of protein 
synthesis has been advanced as a contributory self healing 
mechanism, which accelerates liver regeneration process [51]. 
Increment of ALP and GGT were also observed in the present 
study. This was in agreement with Reyes-Gordillo et al. (2007) 
[52] who recorded significant increase in ALP and GGT 
biomarker after intoxication of rats with CCl4. Hamed (2011) [53] 
added that GGT alone is a poor indicator of cytotoxicity and 
suggested the combination of other markers like AST, ALT and 
LDH for accurate detection and early diagnosis. Serum enzymes 
elevation can be explained to the increase in hepatic cell 
membrane fluidity that led to enzyme release into circulation [12, 
49]. Treatment with D. viscosa extracts attenuated the increased 
level of serum enzymes and caused a subsequent recovery 
towards normalization. This give an additional support that D. 
viscosa extracts are able to condition the hepatocytes, accelerate 
regeneration of parenchyma cells, protect against membrane 
fragility and decrease leakage of the enzymes into circulation. 
Therefore, plant extracts acted by the same mode of action of 
silymarin [12] 
The in vitro screening of the plant extracts confirmed the in vivo 
study, where ethanol extract recorded the highest percentage in 
scavenging DPPH free radicals revealing its high antioxidant 
effect followed by toluene extract. 
The most remarkable histopathological characteristics of CCl4-
induced hepatotoxicity are massive centrilobular necrosis, 
ballooning degeneration, cellular infiltration and steatosis [12]. 
This was in accordance with the present finding of massive 
deformation of hepatic cells architecture. In D. viscosa and 
silymarin treated groups, hepatocyte degeneration, necrosis and 
infiltration of inflammatory cells were all apparently ameliorated. 
We compare the anti-fibrogenic effects of silymarin with extracts 
and the results exhibited that ethanol extract had higher potency 
in inhibiting collagen deposition and fibrosis severity. 
Any curative abilities of D. viscosa is most likely associated with 
the pharmacological effects brought by the synergistic 
combination of several compounds, namely, saponins, 
flavonoids, di- and triterpenes, and a complex mixture of phenolic 
compounds present in the plant [54]. Previous phytochemical 
investigations of Dodonaea viscosa have resulted in the isolation 
of flavonoids [1-4], saponins, and diterpenes [2]. Treatment with 
the flavonoidal drug (D. viscosa) against lead-poisoned rats 
exhibited a significant decrease in the levels of glycoproteins and 
sialic acid contents in the liver [55].  
 
Conclusions 
Dodonaea viscosa has the ability to down regulate free radicals 
elevation, ameliorate hepatic function enzymes, reduce fibrosis 
severity and normalize the hepatic cells architecture. Dodonaea 
viscosa ethanolic extract recorded the most potent effect in 
improving the selected parameters. Further in vivo studies are 
required in order to identify the molecules responsible of the 
pharmacological activity in the hope to can use this species 
(crude extract, fractions, sub fractions or pure compounds) in the 
therapy of liver fibrosis and in a clinical trial for its use as a 
complementary drug capable to attenuate liver fibrotic 
mechanism or reduce disease complication. 
 
Acknowledgements  
The authors are thankful for Dr. Farag Abd- Allah Elghamdy, King 
Abdul-Aziz University for identification of plant. We are grateful 
for Dr. Mohamed A. Ibrahim, Faculty of Pharmacy, Mississippi, 
USA for carrying out HRESI/MS. 
Hamed et al. International Journal of Phytomedicine 4 (1) 27-39 [2012] 
 









[1]. van-Heerden FR, Viljoen AM, van-Wyk 
BE. The major flavonoid of Dodonaea 
angustifolia. Fitoterapia 2000;71:602–
604. 
[2]. Niu HM, Zeng DQ, Long CL, Peng YH, 
Wang YH, Luo JF, Wang HS, Shi YN, 
Tang GH, Zhao FW. Clerodane 
diterpenoids and prenylated flavonoids 
from Dodonaea viscosa. J Asian Nat 
Prod Res 2010;12:7–14. 
[3]. Shanmugavasana A, Ramachandran 
T. Investigation of the extraction 
process and phytochemical 
composition of preparations of 
Dodonaea viscosa (L.) Jacq. J 
Ethnopharmacol 2011;137:1172-1176. 
[4]. Pengelly A. Medicinal activity of 
Dodonaea viscosa—A preliminary 
study. Regional Industries Research 
and Development Corporation, 
Australia, 2008. 
[5]. Anilreddy B: Preparation, 
characterization and biological 
evaluation of some overview of 
Dodonaea viscosa Linn. J Pharmaceut 
Sci Tech 2009;1:1–9. 
[6]. Rani MS, Rao, SP, Mohan K. 
Dodonaea viscosa Linn—an overview. 
J Pharmaceut Res Health Care 
2009;1:97–112. 
[7]. Khalil MN, Sperotto SJ, Manfron PM: 
Anti-inflammatory activity and acute 
toxicity of Dodonaea viscosa. 
Fitoterapia 2006;77:478 – 480. 
[8]. Meenu J, Sunil S, Manoj K. Evaluation 
of antihyperglycemic activity of 
Dodonaea viscosa leaves in normal 
and STZ-diabetic rats. Int J Pharm 
Pharmaceut Sci 2011;3:69-74. 
[9]. Veerapur VP, Prabhakar KR, Parihar 
VK, Bansal P, Srinivasan KK, 
Priyadarsini KI, Unnikrishnan MK: 
Antidiabetic, hypolipidaemic and 
antioxidant activity of Dodonaea 
viscosa aerial parts in streptozotocin-
induced diabetic rats. Int J Phytomed 
2010;2:59–70. 
[10]. Kanter M, Coskun O, Budancamanak 
M. Hepatoprotective effects of Nigella 
sativa L. and Urtica dioica L. on lipid 
peroxidation, antioxidant enzyme 
systems and liver enzymes in carbon 
tetrachloride-treated rats. World J 
Gastroenterol 2005;11:6684–6688. 
[11]. Nevin KG, Vijayamma L.  Effect of 
Aerva lanata against hepatotoxicity of 
carbon tetrachloride in rats. Environ 
Toxicol Pharmacol 2005;20:471-477. 
[12]. Shankar GNL, Manavalan R, 
Venkappayya D, Raj CD. 
Hepatoprotective and antioxidant 
effects of Commiphora berryi (Arn) 
Engl bark extract against CCl4-induced 
oxidative damage in rats. Food Chem 
Toxicol 2008;46:3182–3185. 
[13]. Mitra SK, Venkataranganna MV, 
Sundaram R, Gopumadhavan S. Effect 
of HD-03, an herbal formulation, on the 
antioxidant defense system in rats. 
Phytother Res 1998;12:114–117. 
[14]. Abu-Gabal NS, Abd-Alla HI, Ahmed 
HH, Al-Saigh SM, Shalaby NMM. 
Efficacy of Aloe vera extracts in 
attenuating neurological 
endangerment-induced by 
dexamethasone in adult male rats. J 
Arab Soc Med Res 2007;2:59-73. 
[15]. Wyk VEB. A broad review of 
commercially important southern 
African medicinal plants. J 
Ethnopharmacol 2008;119:342–355. 
[16]. Agrawal PK, Bansal MC. Flavonoid 
glycosides. In: studies in organic 
chemistry 39, 13C-NMR of flavonoids, 
Agrawal PK (Ed.), Elsevier science, 
New York, U.S.A., 1989. 
[17]. Mabry TJ, Markham KR, Thomas MB. 
The systematic identification of 
flavonoids. Springer-Verlag, Berlin, 
1970;pp. 41–164. 
[18]. Markham KR. Techniques of flavonoid 
identification. Academic Press Inc, Ltd, 
London, 1982;pp. 84. 
[19]. Harborne JB, Mabry TJ. The 
Flavonoid: Advances in research, 
Chapman and Hall Ltd, London, 
1982;pp. 1-18. 
[20]. Chen HY, Lin YC, Hsiech CL. 
Evaluation of antioxidants activity of 
aqueous extract of some selected 
nutraceutical herbs. Food Chem 
2007;104:1418-1424. 
[21]. Marsillach J, Camps J, Ferré N, 
Beltran R, Rul A, Mackness B, Michael 
MM, Joven J. Paraoxonase-1 is related 
to inflammation, fibrosis and PPAR 
delta in experimental liver disease. 
BMC Gastroenterol 2009;9:3.   
[22]. Yuvaraj P, Subramoniam A. 
Hepatoprotective property of 
Thespesia populnea against carbon 
tetrachloride induced liver damage in 
rats. J Basic Clin Physiol Pharmacol 
2009;20:169-177. 
[23]. Buege JA, Aust SD. Microsomal lipid 
peroxidation. Meth Enzymol 
1978;52:302-310. 
[24]. Moron MS, Depierre JW, Mannervik B. 
Level of glutathione, glutathione 
reductase and glutathone-S-
transferase activities in rat lung and 
liver. Biochimica Biophysica Acta 
1979;582:67-78. 
[25]. Nishikimi M, Rae NA, Yagi K. The 
occurrence of superoxide anion in the 
action of reduced phenazine 
methosulphate and molecular oxygen. 
Biochem Biophys Res Commun 
1972;46:849-853. 
[26]. Gella FJ, Olivella T, Cruz PM, Arenas 
J, Moreno R, Durban R, Gomez JA. A 
simple procedure for routine 
Hamed et al. International Journal of Phytomedicine 4 (1) 27-39 [2012] 
 




determination of  aspartate 
aminotransferase and alanine 
aminotransferase with pyridoxal 
phosphate. Clin Chem Acta 
1985;153:241-247. 
[27]. Rosalki SB, Foo AY, Burlina A. 
Multicenter evaluation of iso-ALP test 
kit for measurement of bone alkaline 
phosphatase activity in serum and 
plasma. Clin Chem 1993;39:648-652. 
[28]. Szasz G. A kinetic photometric method 
for serum γ-glutamyl transpeptidase. 
Clin Chem 1969;15:124-136. 
[29]. Bradford MM. A rapid and sensitive 
method for the quantitation of 
microgram quantities of protein utilizing 
the principle of protein-dye binding. 
Anal Biochem 1976;72:248-254. 
[30]. Suzuki H, Suzuki K. Rat hypoplastic 
kidney (hpk/hpk) induces renal 
anemia, hyperparathyroidism, and 
osteodystrophy at the end stage of 
renal failure. J Vet Med Sci 
1998;60:1051-1058. 
[31]. Leenhouts PW. Notes on the extra-
Australian species of Dodonaea 
(Sapindaceae). Blumea 1983;28:271-
289. 
[32]. Horie T, Ohtsurs Y, Shibata K, 
Yamashita K, Tsukayama M, 
Kawamura Y. 13C NMR special 
assignment of the a-ring of 
polyoxgenated flavones. 
Phytochemistry 1998;47:865–874. 
[33]. Rashid MA, Armstrong JA, Gray AI, 
Waterman PG. Alkaloids, flavonoids 
and coumarins from Drummondita 
hassellil and D. calida. Phytochemistry 
1992;31:1265–1269. 
[34]. Salah NAM, Mansour RMA, Markham 
KR. An acylated isorhamnetin 
glycoside from Aerva javanica. 
Phytochemistry 1990;29:1344-1345. 
[35]. Halim AF, Saad HEA, Hashish NE. 
Flavonol glycosides from Nitraria 
retusa. Phytochemistry 1995;40:349-
351. 
[36]. Sachdev K, Kulshreshtha DK. 
Flavonoids from Dodonaea viscosa. 
Phytochemistry 1983;22:1253–1256. 
[37]. Getie MG, Gebre-Miriam T, Rietz R, 
Neubert R. Distribution of quercetin, 
kaempferol and isorhamnetin in some 
Ethiopian medicinal plants used for 
treatment of dermatological disorders. 
Ethiopian Pharmacol J 2000;18:25–34. 
[38]. Abdel-Mogib M, Basaif SA, Asiri AM, 
Sobahi TR, Batterjee SM. New 
clerodane diterpenoid and flavonol-3-
methyl ethers from Dodonaea viscosa. 
Pharmazie 2001;56:830-831. 
[39]. Fukumoto LR, Mazz G. Assessing 
antioxidant and prooxidant activities of 
phenolic compounds. J Agric Food 
Chem 2000;48:3597–3604. 
[40]. Jeong JM, Choi CH, Kang SK, Lee 
IH, Lee JY, Jung H. Antioxidant and 
chemosensitizing effects of flavonoids 
with hydroxy and/or methoxy groups 
and structure-activity relationship. J 
Pharm Pharm Sci 2007;10:537-546. 
[41]. Rice-Evans CA, Miller NJ, Paganga G. 
Structure-antioxidant relationships of 
flavonoids and phenolic acids. Free 
Radic Biol Med 1996;20:933–956. 
[42]. Saskia ABE, Acker V, Van-Den Berg 
DJ, Bast A: Structural aspects of 
antioxidant activity of flavonoids. Free 
Radic Biol Med 1996;20:331–342. 
[43]. Teffo LS, Aderogba MA, Eloff JN. 
Antibacterial and antioxidant activities 
of four kaempferol methyl ethers 
isolated from Dodonaea viscosa Jacq. 
var. angustifolia leaf extracts. S Afr J 
Bot 2010;76:25-29. 
[44]. Manna P, Sinha M, Sil PC. Aqueous 
extract of Terminalia arjuna prevents 
carbon tetrachloride induced hepatic 
and renal disorders. BMC Comp Alt 
Med 2006;6:33-42.  
[45]. April JE, Michael PR, Gwendolyn LK, 
Edward JN, Evan BS. Experimental 
diabetes attenuates cerebral cortical –
evoked forelimb motor responses. 
Diabetes 2005;54:2764-2771. 
[46]. Gharib B, Abd-Allah OM, Dessein H, 
De-Reggi M. Development of 
eosinophil peroxidase activity and 
concomitant alteration of antioxidant 
defenses in the liver of mice infected 
with Schistosoma mansoni. J Hepatol 
1999;30:594-602. 
[47]. Mansour HH, Hafez HF, Fahmy, NM. 
Silymarin modulates cisplatin-induced 
oxidative stress and hepatotoxicity in 
rats. J Biochem Mol Biol 2006;39:656-
661. 
[48]. Yadav NP, Pal A, Shanker K, 
Bawankule DU, Gupta AK, Darokar 
MP, Khanuja SPS. Synergistic effect of 
silymarin and standardized extract of 
Phyllanthus amarus against CCl4-
induced hepatotoxicityin Rattus 
norvegicus. Phytomed 2008;15:1053–
1061. 
[49]. Opoku AR, Ndlovu IM, Terblanche SE, 
Hutchings AH.  In vivo 
hepatoprotective effects of Rhoicissus 
tridentata subsp. cuneifolia, a 
traditional Zulu medicinal plant, against 
CCl4-induced acute liver injury in rats. 
South African J Botany 2007;73:372–
377. 
[50]. Romero FJ, Bosch-Morell F, Romero 
MJ, Jareńo EJ, Romero B, Marίn N, 
Romá J. Lipid peroxidation products 
and antioxidants in human disease. 
Environ Health Perspectives 
1998;106:1229–1234. 
[51]. Sharma N, Shukla S. Hepatoprotective 
potential of aqueous extract of Butea 
monosperma against CCl4 induced 
damage in rats. Exp Toxicol Pathol 
2011;63:671-676. 
[52]. Reyes-Gordillo K, Segovia J, 
Shibayama M, Vergara P, Moreno MG, 
Muriel P. Curcumin protects against 
acute liver damage in the rat by 
inhibiting NF-kappa B, proinflammatory 
cytokines production and oxidative 
Hamed et al. International Journal of Phytomedicine 4 (1) 27-39 [2012] 
 




stress. Biochim Biophys Acta 
2007;1770:989-996.  
[53]. Hamed MA. Metabolic profile of rats 
after one hour of intoxication with a 
single oral dose of ethanol. J 
Pharmacol Toxicol 2011;6:158-165. 
[54]. Wagner H. Trends and challenge: 
phytomedicine: research in the new 
millennium. In: Yaniv Z, Bachrach U 
(Eds.), Handbook of Medicinal Plants. 
Haworth press, New York, 2005;pp. 3–
25. 
[55]. Sivanesan D, Selvi VAVT, Bhakyaraj 
R, Arunachalam T. Protective effect of 
Dodonaea viscosa (L) against lead 
acetate induced altered glycoprotein 
profiles in rats. E J Chem 2009;6:725-
728. 
 
